- Report
- June 2024
- 200 Pages
Global
From €7593EUR$7,950USD£6,349GBP
- Report
- January 2022
- 60 Pages
Global
From €3772EUR$3,950USD£3,155GBP
- Report
- April 2018
- 112 Pages
Global
From €4489EUR$4,700USD£3,754GBP
- Book
- July 2019
- 544 Pages
- Book
- February 2010
- 268 Pages

Insulin resistance is a condition in which the body's cells do not respond normally to the hormone insulin. This can lead to high blood sugar levels, which can cause a range of health problems. Endocrinology is the medical specialty that deals with the diagnosis and treatment of disorders related to hormones and the endocrine system. Insulin resistance is a major concern in endocrinology, as it can lead to type 2 diabetes, obesity, and other metabolic disorders.
Treatment for insulin resistance typically involves lifestyle changes such as diet and exercise, as well as medications. Companies in the insulin resistance market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. Show Less Read more